Emerging therapies in sickle cell disease.

British Journal of Haematology
Amina Nardo-MarinoDavid Rees

Abstract

Despite sickle cell disease (SCD) being the most common and severe inherited condition worldwide, therapeutic options are limited. To date, hydroxyurea remains the main treatment option in SCD. However, in the last decade the numbers of interventional clinical trials focussing on therapies for SCD have increased significantly. Many new drugs with various pharmacological targets have emerged and, although the majority have failed to show benefit in clinical trials, some have produced encouraging results. It seems probable that more drugs will soon become available for the treatment of SCD. Furthermore, promising clinical trials with improved outcomes have recently changed the perspective of curative therapies in SCD. Nevertheless, the application of novel therapeutic agents and potential curative treatments will most likely be limited to high-income countries and, thus, will remain unavailable for the majority of people with SCD in the foreseeable future.

References

Sep 20, 1984·The New England Journal of Medicine·F L JohnsonF T Billings
Jan 1, 1984·Acta Haematologica·M A ZagoC Bottura
Jan 1, 1981·Acta Haematologica·N O OsamoA A Famodu
May 1, 1983·The Journal of Pediatrics·J GreenbergE Schwartz
Mar 17, 1994·The New England Journal of Medicine·T C GriffinG R Buchanan
May 1, 1997·The Journal of Laboratory and Clinical Medicine·T WunA Cheung
Nov 14, 2000·American Journal of Hematology·B S BaligaY M Yang
Aug 23, 2001·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·C WambebeO Ogunyale
Jan 15, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M C WaltersUNKNOWN Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease
Mar 29, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·K KiesslingJ C Ellory
Jul 9, 2002·British Journal of Haematology·Efemwonkiekie W IyamuToshio Asakura
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Martin H SteinbergMichael Terrin
Apr 18, 2003·American Journal of Hematology·Betty S PaceSteven R Goodman
Jul 25, 1963·The New England Journal of Medicine·J E SALVAGGIOC H BANOV
Aug 1, 2007·Pediatric Transplantation·Tom V AdamkiewiczAndrew M Yeager
Dec 17, 2009·The New England Journal of Medicine·Matthew M HsiehJohn F Tisdale
Aug 19, 2011·British Journal of Haematology·Charles T QuinnUNKNOWN Investigators of the Comprehensive Sickle Cell Centers
Feb 22, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Naynesh R KamaniShalini Shenoy
Nov 23, 2012·British Journal of Clinical Pharmacology·Joseph A JakubowskiChristopher D Payne
Apr 18, 2013·British Journal of Haematology·Clarisse Lopes de Castro LoboJane S Hankins
May 23, 2013·Blood·Franco LocatelliUNKNOWN Eurocord and European Blood and Marrow Transplantation (EBMT) group
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Matthew M HsiehJohn F Tisdale
Aug 13, 2014·Artificial Organs·Hemant MisraAbraham Abuchowski
Sep 10, 2014·JAMA : the Journal of the American Medical Association·Barbara P YawnJoylene John-Sowah
Sep 14, 2014·Blood Reviews·Javier Bolaños-Meade, Robert A Brodsky
Jan 24, 2015·American Journal of Hematology·Deepa ManwaniPatricia A Shi
Dec 9, 2015·The New England Journal of Medicine·Matthew M HeeneyUNKNOWN DOVE Investigators
Apr 5, 2016·Hematology/oncology Clinics of North America·Thomas N Williams
Aug 24, 2016·British Journal of Haematology·Marilyn J TelenMaria Lindgren
Dec 14, 2016·The New England Journal of Medicine·Kenneth I AtagaRussell P Rother

❮ Previous
Next ❯

Citations

Oct 2, 2020·The International Journal of Health Planning and Management·Konathala GeethakumariBontha V Babu
Apr 7, 2021·Biochemical and Biophysical Research Communications·Shaimaa M MohiAsaad A Khalaf
Jul 3, 2021·International Journal of Molecular Sciences·Dito AnurogoJeanne Adiwinata Pawitan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

British Dental Journal
A Tynan
Southern Medical Journal
Amanda Redden Hathaway
© 2021 Meta ULC. All rights reserved